Deciphering tumor metabolites: emerging technologies shaping clinical implications
Trends in Cancer · 2026-08 · 12 (8) · 708-724
DOI: 10.1016/j.trecan.2026.04.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2026-08. Verfasst von Xiao-Hui Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, PR China; Depart…. Hauptthemen laut MEDLINE: Metabolomics, Neoplasms, Biomarkers, Tumor, Metabolome. Die Arbeit nennt 110 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Metabolites exert pleiotropic effects that govern tumor progression. This review evaluates current platforms and technologies for metabolite detection, alongside emerging strategies for functional research. These innovations have identified novel metabolites and revealed their previously unrecognized functions in tumor biology. Furthermore, the integration of advanced algorithms has facilitated the clinical application of metabolites in diagnosis, patient stratification, and therapeutic target discovery. However, critical limitations remain, particularly related to methodological constraints and tumor metabolic heterogeneity. We, therefore, outline a forward-looking vision underscoring the need for next-generation technologies and deep learning frameworks to enhance functional insights and clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, PR China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, X. H., Huang, L., Tian, P., Shao, Z. M., & Xiao, Y. (2026). Deciphering tumor metabolites: emerging technologies shaping clinical implications. Trends in Cancer, 12(8), 708-724. https://doi.org/10.1016/j.trecan.2026.04.004
Vancouver
Zhu XH, Huang L, Tian P, Shao ZM, Xiao Y. Deciphering tumor metabolites: emerging technologies shaping clinical implications. Trends in Cancer. 2026;12(8):708-724. doi:10.1016/j.trecan.2026.04.004
BibTeX
@article{Zhu2026,
author = {Zhu, Xiao-Hui and Huang, Liang and Tian, Pu and Shao, Zhi-Ming and Xiao, Yi},
title = {Deciphering tumor metabolites: emerging technologies shaping clinical implications},
journal = {Trends in Cancer},
year = {2026},
volume = {12},
number = {8},
pages = {708--724},
doi = {10.1016/j.trecan.2026.04.004}
}
EUVIMED